Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018;62(3):1241-1245.
doi: 10.3233/JAD-170581.

The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease

Elena Tamagno  1   2 , Michela Guglielmotto  1   2 , Debora Monteleone  1   2 , Giusi Manassero  1   2 , Valeria Vasciaveo  1   2 , Massimo Tabaton  3
Affiliations
Review

The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease

Elena Tamagno et al. J Alzheimers Dis. 2018.

Abstract

Amyloid-β (Aβ) has been proposed as a biomarker and a drug target for the therapy of Alzheimer's disease (AD). The neurotoxic entity and relevance of each conformational form of Aβ to AD pathology is still under debate; Aβ oligomers are considered the major killer form of the peptide whereas monomers have been proposed to be involved in physiological process. Here we reviewed some different effects mediated by monomers and oligomers on mechanisms involved in AD pathogenesis such as autophagy and tau aggregation. Data reported in this review demonstrate that Aβ monomers could have a major role in sustaining the pathogenesis of AD and that AD therapy should be focused not only in the removal of oligomers but also of monomers.

Keywords: Alzheimer’s disease; Aβ monomers; Aβ oligomers; autophagy; tau protein.

PubMed Disclaimer

References

    1. Selkoe DJ (2001) Alzheimer’s disease: Genes, proteins, and therapy. Physiol Rev 81, 741–766. - PubMed
    1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3, 186–191. - PubMed
    1. Guo JP, Arai T, Miklossy J, McGeer PL (2006) Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer’s disease. Proc Natl Acad Sci USA 103, 1953–1958. - PMC - PubMed
    1. Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, Lewis J, Hutton M, Tolnay M, Jucker M (2007) Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol 171, 2012–2020. - PMC - PubMed
    1. Kepp KP (2012) Bioinorganic chemistry of Alzheimer’s disease. Chem Rev 112, 5193–5239. - PubMed